Ito K - Search Results

1

A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial.

Hori K, Nishio S, Ushijima K, Kasamatsu Y, Kondo E, Takehara K, Ito K. Hori K, et al. Among authors: ito k. J Gynecol Oncol. 2021 Jul;32(4):e64. doi: 10.3802/jgo.2021.32.e64. J Gynecol Oncol. 2021. PMID: 34085798 Free PMC article. Clinical Trial.

2

[A case of uterine endometrial cancer complicated post transfusion fatal fulminant hepatitis caused by hepatitis B virus with DNA mutation in precore region].

Itani Y, Ito K, Hori K, Tamori N. Itani Y, et al. Among authors: ito k. Nihon Sanka Fujinka Gakkai Zasshi. 1995 Oct;47(10):1075-8. Nihon Sanka Fujinka Gakkai Zasshi. 1995. PMID: 8522887 Japanese. No abstract available.

3

Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer.

Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H, Shirasaka T. Kondo K, et al. Among authors: ito k. Oncology. 1996 Jan-Feb;53(1):64-7. doi: 10.1159/000227537. Oncology. 1996. PMID: 8570135 Clinical Trial.

4

[Utility of predeposit autologous blood donation by switch back method combined with recombinant human erythropoietin in gynecological surgery].

Itani Y, Ito K, Hori K, Tamori N, Adachi S. Itani Y, et al. Among authors: ito k. Nihon Sanka Fujinka Gakkai Zasshi. 1996 Mar;48(3):221-8. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8721057 Japanese.

5

A phase I study of cisplatin i.p. and carboplatin i.v. with G-CSF in patients with ovarian cancer.

Adachi S, Ito K, Itani Y, Noda T, Shintani M, Kawai S, Beppu K, Ito A, Saito K, Hisanaga H, Fukumoto Y, Tomii Y, Masuda M. Adachi S, et al. Among authors: ito k, ito a. Oncol Rep. 1999 Mar-Apr;6(2):311-5. doi: 10.3892/or.6.2.311. Oncol Rep. 1999. PMID: 10022995 Clinical Trial.

6

A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies.

Ito K, Adachi S, Itani Y, Koyama M, Hori K, Chin R, Shintani M, Beppu K, Kawai S, Saito K. Ito K, et al. Jpn J Clin Oncol. 1999 Jun;29(6):299-302. doi: 10.1093/jjco/29.6.299. Jpn J Clin Oncol. 1999. PMID: 10418559 Clinical Trial.

7

Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer.

Adachi S, Itani Y, Ito K, Noda T, Shintani M, Saito K, Furukawa N, Tomii Y. Adachi S, et al. Among authors: ito k. Oncol Rep. 2001 Jan-Feb;8(1):27-31. Oncol Rep. 2001. PMID: 11115564 Clinical Trial.

8

A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer.

Adachi S, Ogasawara T, Ito K, Koyama M, Nagano T, Suzuki A, Yamada T, Nakata Y, Ozawa M. Adachi S, et al. Among authors: ito k. Oncol Rep. 2001 Mar-Apr;8(2):285-8. Oncol Rep. 2001. PMID: 11182041 Clinical Trial.

9

[Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer].

Ito K, Adachi S, Iijima T, Nakatsuji Y, Kimura T, Nobunaga T. Ito K, et al. Gan To Kagaku Ryoho. 2003 Jan;30(1):141-4. Gan To Kagaku Ryoho. 2003. PMID: 12557720 Japanese.

10

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin.

Ueno Y, Enomoto T, Otsuki Y, Sugita N, Nakashima R, Yoshino K, Kuragaki C, Ueda Y, Aki T, Ikegami H, Yamazaki M, Ito K, Nagamatsu M, Nishizaki T, Asada M, Kameda T, Wakimoto A, Mizutani T, Yamada T, Murata Y. Ueno Y, et al. Among authors: ito k. Cancer Lett. 2006 Sep 28;241(2):289-300. doi: 10.1016/j.canlet.2005.10.035. Epub 2006 Feb 3. Cancer Lett. 2006. PMID: 16459017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,175 results

Search Page

Filters